JAGXJaguar Health, Inc.

Nasdaq jaguar.health


$ 3.44 $ -0.04 (-1.15 %)    

Tuesday, 02-Jul-2024 13:15:20 EDT
QQQ $ 485.17 $ 5.28 (1.1 %)
DIA $ 391.59 $ 0.75 (0.19 %)
SPY $ 546.85 $ 3.11 (0.57 %)
TLT $ 90.18 $ -0.49 (-0.55 %)
GLD $ 214.89 $ -0.38 (-0.18 %)
$ 3.48
$ 3.49
$ 3.42 x 100
$ 0.00 x 0
$ 3.41 - $ 3.59
$ 3.07 - $ 41.76
379,784
na
9.21M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-22-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-17-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 04-03-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-21-2019 03-31-2019 10-Q
22 04-10-2019 12-31-2018 10-K
23 11-19-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-09-2018 12-31-2017 10-K
27 11-20-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-29-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 06-26-2015 03-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jaguar-health-to-present-phase-3-ontarget-trial-results-for-its-cancer-supportive-care-drug-crofelemer-on-or-before-july-23-2024

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including particip...

 jaguar-health-and-magdalena-biosciences-executes-out-license-deal-with-for-botanical-drug-candidate-for-schizophrenia

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for s...

 whats-going-on-with-jaguar-health-stock

Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order t...

 why-jaguar-health-stock-is-tanking

Jaguar Health shares are falling Monday after the company announced a 1-for-60 reverse stock split. The company will effect a r...